126674-77-9

Basic information

• Product Name: 2-AMINO-4,6-DIFLUOROBENZOIC ACID
• Synonyms: 2-AMINO-4,6-DIFLUOROBENZOIC ACID;BUTTPARK 49\07-42;2-Amino-4,6-difluorobenzoic acid ,97%;2-Carboxy-3,5-difluoroaniline, 4,6-Difluoroanthranilic acid;2-AMino-4,6-difluorobenzoic acid 97%;Benzoic acid, 2-aMino-4,6-difluoro-;2-AMino-4,6-difluorobenzoic acid, 6-difluorobenzoic acid
• CAS NO: 126674-77-9
• Molecular Formula: C₇H₅F₂NO₂
• Molecular Weight: 173.12
• Mol File: 126674-77-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 305.752 °C at 760 mmHg
• Flash Point: 138.714 °C
• Appearance: /
• Density: 1.536
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.578
• PKA: 3.95±0.10(Predicted)
• Sensitive: Air Sensitive
• CAS DataBase Reference: 2-AMINO-4,6-DIFLUOROBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AMINO-4,6-DIFLUOROBENZOIC ACID(126674-77-9)
• EPA Substance Registry System: 2-AMINO-4,6-DIFLUOROBENZOIC ACID(126674-77-9)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 126674-77-9(Hazardous Substances Data)

Usage

General Description

2-Amino-4,6-Difluorobenzoic Acid is a chemical compound that falls under the category of organofluorine compounds, specifically it is a fluorobenzoic acid. It carries the molecular formula of C7H5F2NO2, and it's structurally characterized by a benzene ring substituted by two fluorine atoms and one amino and carboxyl group. Applications or uses of this chemical can depend on its properties and reactions. Information about its safety and handling precautions or hazards may not be readily available, hence it’s important to handle it following standard laboratory practices or professional guidelines. The chemical can be identified by its CAS registry number 352-29-2 for research and cataloging purposes.

InChI:InChI=1/C7H5F2NO2/c8-3-1-4(9)6(7(11)12)5(10)2-3/h1-2H,10H2,(H,11,12)

Upstream product

• 372-39-4 3,5-difluoroaniline 
• 940054-61-5 N-(3,5-difluorophenyl)-2-hydroxyiminoacetamide 
• 190011-84-8 2-amino-4,6-difluorobenzonitrile 
• 126674-93-9 4,6-difluoro-1H-indole-2,3-dione 

Downstream Products

• 59-31-4 2-quinolone 
• 379228-58-7 5,7-difluoroquinazolin-4(3H)-one 
• 379228-57-6 methyl 2-amino-4,6-difluorobenzoate 
• 1378963-19-9 1-[4-(7,9-difluoro-5,6-dihydro-4H-pyrrolo[1,2-a][1,4]benzodiazepin-4-yl)phenyl]ethanone hydrochloride 
• 1379150-67-0 1-[4-(7,9-difluoro-6H-pyrrolo[1,2-a][1,4]benzodiazepin-4-yl)phenyl]ethanone 
• 1616598-46-9 C₂₃H₂₅F₂N₇O₂ 
• 940054-63-7 2-aminomethyl-3,5-difluorophenylamine 
• 940054-64-8 3-(2-amino-4,6-difluorobenzylamino)-pyrrolidine-2,5-dione 
• 887351-13-5 2,4-difluoro-6-iodobenzoic acid 
• 1609122-59-9 5-[2-((E)-3-diethylaminoprop-1-enyl)-4-fluorobenzenesulfonylamino]-7-fluoro-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylic acid 
• 1609122-84-0 methyl 7-fluoro-5-{4-fluoro-2-[(R)-1-(2,2,2-trifluoro-acetyl)pyrrolidin-3-ylmethyl]benzenesulfonylamino}-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate 
• 1609122-83-9 methyl 7-fluoro-5-[4-fluoro-2-((R)-1-pyrrolidin-3-ylmethyl)benzene-sulfonylamino]-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate 
• 1609122-56-6 5-[2-(3-diethylaminopropyl)-4-fluorobenzenesulfonylamino]-7-fluoro-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylic acid 
• 1609122-80-6 2-benzyloxy-6-(2,2-dimethylpropionylamino)-4-fluorobenzoic acid 

Relevant articles and documents

TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY

The present invention relates to quinazolinones and related compounds which degrade PARP14 and are useful, for example, in the treatment of cancer and inflammatory diseases.

Process research and development for the kilogram manufacture of the SRC kinase inhibitor AZD0530

Process research and development of a synthetic route towards a novel SRC kinase inhibitor is described. The Medicinal Chemistry route was very long and suffered from extensive use of chlorinated solvents and chromatography. A number of steps in the Medic

CHEMICAL PROCESS

The present invention relates to chemical processes useful in the manufacture of the compound 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]- 5-tetrahydropyran-4-yloxyquinazoline (the active entity within AZD0530), to intermed